Lanadelumab
Lanadelumab
Lanadelumab (pronounced lan-uh-del-yoo-mab) is a monoclonal antibody designed for the prevention of attacks in patients with hereditary angioedema (HAE).
Etymology
The name "Lanadelumab" is derived from the Latin roots "lana" meaning wool, "del" meaning of the, and "umab" a common suffix for monoclonal antibodies.
Usage
Lanadelumab is used to prevent attacks of hereditary angioedema (HAE) in people aged 12 years and older. HAE is a rare disorder that causes attacks of swelling and inflammation in various parts of the body, including the hands, feet, face, and airways. Lanadelumab works by decreasing the activity of an enzyme in the body that contributes to these attacks.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Hereditary angioedema: A disorder characterized by recurrent episodes of severe swelling (angioedema).
- Enzyme: A protein that speeds up chemical reactions in the body.
Side Effects
Common side effects of Lanadelumab include injection site reactions (pain, redness, and hardening of the skin), headache, and rash. Serious side effects can include allergic reactions.
Precautions
Before using Lanadelumab, inform your doctor about your current list of medications, over the counter products, allergies, pre-existing diseases, and current health conditions.
Interactions
Drug interactions may change how your medications work or increase your risk for serious side effects. Share a list of all medicines that you use with your doctor and pharmacist.
External links
- Medical encyclopedia article on Lanadelumab
- Wikipedia's article - Lanadelumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski